1559.4000 -14.60 (-0.93%)
NSE Jul 30, 2025 15:31 PM
Volume: 1.4M
 

1559.40
-0.93%
Asit C Mehta Investment Interrmediates
Cipla's "Future Fit" strategy outlines ambitious growth objectives, including becoming India’s 2nd largest pharmaceutical company, leading South Africa’s prescription and OTC markets, ranking 2nd in U.S. respiratory generics, and doubling international revenue.
Cipla Ltd. has an average target of 1713.00 from 9 brokers.
More from Cipla Ltd.
Recommended